<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CELF2 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CELF2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>CUGBP Elav-Like Family Member 2</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>CUG-BP2, CUGBP2, NAPOR</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>10p21.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>10689</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>601128</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000149532</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>O95393</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>512 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~57 kDa</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Primary Function</td>
</tr>
<tr>
<td class="label">CELF1</td>
<td>Myotonic dystrophy</td>
</tr>
<tr>
<td class="label">CELF2</td>
<td>Neuronal splicing</td>
</tr>
<tr>
<td class="label">CELF3-6</td>
<td>Brain development</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/dementia" style="color:#ef9a9
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CELF2 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CELF2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>CUGBP Elav-Like Family Member 2</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>CUG-BP2, CUGBP2, NAPOR</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>10p21.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>10689</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>601128</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000149532</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>O95393</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>512 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~57 kDa</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Primary Function</td>
</tr>
<tr>
<td class="label">CELF1</td>
<td>Myotonic dystrophy</td>
</tr>
<tr>
<td class="label">CELF2</td>
<td>Neuronal splicing</td>
</tr>
<tr>
<td class="label">CELF3-6</td>
<td>Brain development</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/dementia" style="color:#ef9a9a">Dementia</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">22 edges</a></td>
</tr>
</table>
CELF2 (CUGBP Elav-Like Family Member 2), also known as CUG-BP2 (CUG triplet repeat RNA-binding protein 2), is a member of the CELF family of RNA-binding proteins that plays critical roles in post-transcriptional gene regulation. This gene encodes a protein characterized by three RNA recognition motifs (RRMs) that enable binding to GU-rich elements (GREs), AU-rich elements (AREs), and CUG repeat sequences in target mRNAs[@barlow2013]. CELF2 is widely expressed in the brain with particularly high levels in the cerebral cortex, hippocampus, and cerebellum, where it regulates alternative splicing, mRNA translation, and RNA stability—processes essential for neuronal function and survival.
The significance of CELF2 in neurodegenerative diseases has become increasingly apparent through genome-wide association studies (GWAS) and functional analyses. CELF2 genetic variants have been linked to increased risk for [Alzheimer's Disease](/diseases/alzheimers-disease) through GWAS signals in multiple cohorts, and altered CELF2 expression has been documented in postmortem brain tissue from Alzheimer's disease patients[@papadopoulou2015]. Furthermore, CELF2 dysregulation contributes to the pathogenesis of [Amyotrophic Lateral Sclerosis (ALS)](/diseases/amyotrophic-lateral-sclerosis) through its role in regulating [TDP-43](/proteins/tdp-43) (encoded by TARDBP) mRNA stability and alternative splicing[@fallini2022].
CELF2 contains three RNA recognition motifs (RRMs) in its N-terminal region, each consisting of approximately 80 amino acids with the conserved RNP1 (octamer) and RNP2 (hexamer) RNA-binding motifs[@luco2011]. These RRMs enable high-affinity binding to specific RNA sequences:
CELF2 participates in multiple post-transcriptional regulatory processes[@sharma2019]:
CELF2 exhibits region-specific and cell-type-specific expression patterns in the central nervous system:
CELF2 has been strongly implicated in Alzheimer's disease pathogenesis through multiple mechanisms[@chen2019]:
APP Processing: CELF2 regulates [APP](/genes/app) mRNA translation and alternative splicing, influencing amyloid-beta production. Studies show that CELF2 knockdown leads to reduced APP expression and amyloid-beta secretion in cellular models.
Tau Alternative Splicing: CELF2 directly regulates the alternative splicing of [tau](/proteins/tau) exon 10, controlling the 4R/3R tau isoform ratio[@berson2012]. Dysregulation of this ratio leads to tau filament formation and neurofibrillary tangle accumulation—the hallmark of [tauopathies](/mechanisms/tau-pathology).
Synaptic Protein Expression: CELF2 controls the translation of synaptic proteins essential for synaptic plasticity and memory formation. Reduced CELF2 expression in Alzheimer's disease brain correlates with synaptic deficits[@papadopoulou2015].
Genetic Association: GWAS have identified CELF2 variants (rs12433612, rs10884520) associated with increased AD risk in European ancestry cohorts. These variants may affect CELF2 expression or splicing patterns.
Transcriptomic Evidence: Single-nucleus RNA sequencing studies have revealed CELF2 dysregulation in specific neuronal subtypes in Alzheimer's disease brain[@ray2023].
CELF2 plays a significant role in ALS pathogenesis through[@fallini2022]:
TDP-43 Regulation: CELF2 regulates the stability and alternative splicing of TARDBP (TDP-43) mRNA. Dysregulated CELF2 leads to altered TDP-43 expression and splicing patterns, contributing to the characteristic TDP-43 proteinopathy observed in most ALS cases.
Motor Neuron Vulnerability: CELF2 is highly expressed in spinal motor neurons, which are selectively vulnerable in ALS. Altered CELF2 splicing patterns have been documented in ALS motor neurons.
Genetic Variants: Rare coding variants in CELF2 have been associated with increased ALS risk in some populations.
CELF2 mutations cause early-onset epilepsy and neurodevelopmental disorders through dysregulation of epilepsy-related gene splicing. Patients with CELF2 mutations present with infantile spasms, intellectual disability, and autism spectrum features.
CELF2 recognizes and regulates RNA through multiple mechanisms[@zhou2017]:
CELF2 is essential for normal brain development and function[@scotti2018]:
CELF2 represents a potential therapeutic target in neurodegenerative diseases[@liu2022]:
CELF2 plays a critical role in cellular stress responses, particularly in neurons exposed to various pathological conditions. Under oxidative stress conditions, CELF2 undergoes post-translational modifications that alter its RNA-binding activity and splicing patterns. This stress-responsive regulation allows neurons to rapidly adjust their gene expression programs in response to environmental challenges.
Oxidative Stress Response: CELF2 expression is upregulated in response to oxidative stress, where it regulates the alternative splicing of stress response genes. This includes genes involved in antioxidant defense, DNA repair, and protein quality control mechanisms.
ER Stress and Unfolded Protein Response: In conditions of endoplasmic reticulum stress, CELF2 modulates the splicing of XBP1 mRNA, a key transcription factor in the unfolded protein response (UPR). This connection is particularly relevant to neurodegenerative diseases characterized by protein misfolding and ER stress.
Heat Shock Response: CELF2 regulates heat shock protein expression through post-transcriptional mechanisms, influencing cellular proteostasis under stress conditions.
Emerging evidence links CELF2 to mitochondrial function and neuronal energy metabolism:
Mitochondrial RNA Processing: CELF2 localizes to mitochondria in neurons and regulates the processing of mitochondrial transcripts. This function is essential for proper mitochondrial function and ATP production.
Calcium Homeostasis: CELF2 influences the expression of calcium-handling proteins, affecting neuronal calcium signaling and excitability.
Metabolic Regulation: Through its role in regulating metabolic enzyme expression, CELF2 affects neuronal glucose metabolism and energy production.
The expression and activity of CELF2 are subject to epigenetic regulation:
DNA Methylation: CELF2 promoter methylation status correlates with expression levels in some brain regions. Altered methylation patterns have been observed in AD brain tissue.
Histone Modifications: Chromatin accessibility at the CELF2 locus is regulated by histone modifications, influencing CELF2 expression during development and disease.
Non-coding RNAs: Various microRNAs target CELF2 mRNA, including miR-9 and miR-124, which are important for neuronal differentiation and function.
While CELF2 is predominantly studied in neurons, it also plays roles in glial cells:
Astrocyte Function: CELF2 regulates astrocyte-specific gene expression, influencing astrocyte support of neuronal function.
Microglial Activation: Altered CELF2 expression in microglia may affect neuroinflammatory responses.
Oligodendrocyte Biology: CELF2 is expressed in oligodendrocytes and may regulate myelination-related gene expression.
The CELF family consists of six members (CELF1-6) with partially overlapping functions:
The high expression of CELF2 in the brain and its specific disease associations make it a particularly important member of this family for neurodegenerative disease research.
Yeast Models: Yeast expression of human CELF2 has been used to study RNA-binding protein function and stress responses.
C. elegans: The CELF2 ortholog in C. elegans (cul-1) has been used to study development and RNA processing.
Zebrafish: Zebrafish models have revealed conserved roles for CELF2 in neural development.
Mouse Models: CELF2 knockout mice show behavioral phenotypes including anxiety and impaired learning, confirming its importance in brain function.
Diagnostic Biomarkers: CELF2 expression in peripheral blood mononuclear cells may serve as a biomarker for neurological disease.
Therapeutic Targeting: Modulating CELF2 activity through small molecules or antisense oligonucleotides represents a potential therapeutic approach.
Genetic Testing: CELF2 variant analysis may help identify at-risk individuals for early intervention.
Several key questions remain about CELF2 function:
CELF2 intersects with multiple neurodegenerative disease pathways:
Protein Aggregation Pathways: CELF2 regulates the expression and splicing of proteins involved in aggregation, including tau, TDP-43, and SOD1. Dysregulation contributes to the hallmark protein aggregates in AD, ALS, and FTD.
Inflammatory Pathways: CELF2 modulates the splicing of immune-related genes, connecting RNA processing to neuroinflammation—a common feature across neurodegenerative diseases.
Metabolic Pathways: Through its role in regulating metabolic enzyme expression, CELF2 links cellular metabolism to neuronal survival and function.
Cellular Stress Responses: CELF2's involvement in oxidative stress, ER stress, and proteostasis pathways positions it at the intersection of cellular stress and neurodegeneration.
Translating CELF2 research into clinical applications:
Biomarker Development: CELF2 expression in peripheral blood cells represents a potential minimally invasive biomarker for neurodegenerative disease diagnosis and progression monitoring.
Therapeutic Target Identification: Understanding CELF2's role in disease pathogenesis has identified RNA processing as a therapeutic target in neurodegeneration.
Personalized Medicine: CELF2 genetic variants may help identify patients who could benefit from RNA-targeted therapies.
Drug Discovery: CELF2 modulators are being developed as potential disease-modifying therapies for AD, ALS, and related conditions.
Beyond neurodegenerative diseases, CELF2 is implicated in neurodevelopmental disorders:
Intellectual Disability: CELF2 mutations are associated with intellectual disability phenotypes.
Autism Spectrum Disorders: Altered CELF2 expression and splicing patterns have been reported in ASD.
Epilepsy: CELF2 mutations cause epileptic encephalopathy in some cases.
Developmental Delay: CELF2-related neurodevelopmental disorders often present with developmental delay and cognitive impairment.
Detailed regional expression analysis:
Hippocampal Subregions: CELF2 expression varies across hippocampal subfields, with highest expression in CA1 pyramidal neurons and the dentate gyrus.
Cortical Layers: Layer-specific expression patterns in the cerebral cortex suggest cell-type-specific functions.
Subcortical Nuclei: High expression in the basal ganglia and thalamus indicates roles in motor control and sensory processing.
Cerebellar Circuits: Purkinje cell expression suggests roles in motor learning and coordination.
CELF2 functions within a network of RNA-binding proteins:
TDP-43 (TARDBP): CELF2 regulates TDP-43 mRNA stability and splicing; both proteins are involved in ALS pathogenesis.
FUS: CELF2 and FUS share common target mRNAs and may have overlapping functions.
hnRNP Proteins: CELF2 interacts with various hnRNP proteins to regulate RNA processing.
Nova Proteins: CELF2 and Nova proteins regulate overlapping sets of synaptic transcripts.
CELF2 is a critical RNA-binding protein with diverse functions in neuronal RNA processing. Its involvement in Alzheimer's disease, ALS, and epilepsy through regulation of tau splicing, TDP-43 expression, and synaptic protein translation makes it an important therapeutic target. The growing understanding of CELF2's role in neurodegeneration is enabling the development of RNA-targeted therapeutic approaches. As research continues, CELF2 may serve as both a biomarker and a target for disease-modifying therapies in neurodegenerative and neurodevelopmental disorders.
The following diagram shows the key molecular relationships involving CELF2 Gene discovered through SciDEX knowledge graph analysis: